Our study revealed that TMEM120B was highly expressed in breast cancer and other malignant carcinomas, and its expression was significantly correlated with advanced TNM stage, positive lymph node metastasis, and poor prognosis. The gene discussed is TMEM120B; the disease is breast cancer.